male incontinence advanced treatments, stem cell therapy male incontinence, ProACT periurethral balloons, male incontinence clinical decision making, Analysis of Treatment Options for Male Stress ...

(UroToday.com) The 2025 European Association of Urology (EAU) Annual Congress held in Madrid, Spain, between March 21 st and 24 th 2025, was host to a thematic session on hot topics in the management ...

The 34rd World Congress of Endourology (WCE) held in Conjunction with the South African Urological Association (SAUA) Meeting in 2016 was held in Cape Town, South Africa from November 8th-12th, 2016.

PSMA and Beyond 2025 antibody drug development (ADC) in prostate cancer, ADC program in advance prostate cancer, PSMA expression, ...

Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial. August 7, 2025 ...

UroToday's exclusive Video Lecture content covering mCRPC Treatment.

BPH - Read the latest BPH research including Full-Text Abstracts as well as "Beyond the Abstract" articles, written by the researchers exclusively for UroToday.

Stone Disease Urinary Retention research including Full-Text Abstracts as well as "Beyond the Abstract" articles, written by the researchers exclusively for UroToday.

(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to a Radiopharmaceutical Therapy Trials with Dosimetry session. Dr.

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

ASCO 2025, prostate cancer, radioligand therapy (RLT), Radioligand Therapies in Prostate Cancer, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), 177Lu-PSMA-617.

UroToday's exclusive Video Lecture content covering Bladder Cancer.